Nasal neuron PET imaging quantifies neuron generation and degeneration
Van de Bittner, Genevieve C.
Riley, Misha M.
O’Neill, Michael J.
Murray, Tracey K.
Smith, Jaclyn E.
Schroeder, Frederick A.
Hooker, Jacob M.Note: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationVan de Bittner, G. C., M. M. Riley, L. Cao, J. Ehses, S. P. Herrick, E. L. Ricq, H. Wey, et al. 2017. “Nasal neuron PET imaging quantifies neuron generation and degeneration.” The Journal of Clinical Investigation 127 (2): 681-694. doi:10.1172/JCI89162. http://dx.doi.org/10.1172/JCI89162.
AbstractOlfactory dysfunction is broadly associated with neurodevelopmental and neurodegenerative diseases and predicts increased mortality rates in healthy individuals. Conventional measurements of olfactory health assess odor processing pathways within the brain and provide a limited understanding of primary odor detection. Quantification of the olfactory sensory neurons (OSNs), which detect odors within the nasal cavity, would provide insight into the etiology of olfactory dysfunction associated with disease and mortality. Notably, OSNs are continually replenished by adult neurogenesis in mammals, including humans, so OSN measurements are primed to provide specialized insights into neurological disease. Here, we have evaluated a PET radiotracer, [11C]GV1-57, that specifically binds mature OSNs and quantifies the mature OSN population in vivo. [11C]GV1-57 monitored native OSN population dynamics in rodents, detecting OSN generation during postnatal development and aging-associated neurodegeneration. [11C]GV1-57 additionally measured rates of neuron regeneration after acute injury and early-stage OSN deficits in a rodent tauopathy model of neurodegenerative disease. Preliminary assessment in nonhuman primates suggested maintained uptake and saturable binding of [18F]GV1-57 in primate nasal epithelium, supporting its translational potential. Future applications for GV1-57 include monitoring additional diseases or conditions associated with olfactory dysregulation, including cognitive decline, as well as monitoring effects of neuroregenerative or neuroprotective therapeutics.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:31731828